Scarica l'app Stockscreener
4.54
2.48%
0.11
Precedente Chiudi:
$4.43
Aprire:
$4.38
Volume 24 ore:
26,989
Relative Volume:
0.33
Capitalizzazione di mercato:
$17.32M
Reddito:
-
Utile/perdita netta:
$1.52M
Rapporto P/E:
-0.7182
EPS:
-6.3213
Flusso di cassa netto:
$-1.14M
1 W Prestazione:
+7.84%
1M Prestazione:
+42.32%
6M Prestazione:
+75.29%
1 anno Prestazione:
-71.84%
Intervallo 1D:
$4.325
$4.71
Intervallo di 1 settimana:
$4.10
$4.71
Portata 52W:
$0.6254
$34.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Nome
Psyence Biomedical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare PBM vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
4.54 | 14.99M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - Kalkine
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development - marketscreener.com
Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Nigeria
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Australia
Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingSeasonality Effect - vinanet.vn
Psyence BioMed Welcomes White House Support for Accelerated U.S. Ibogaine Development - Quiver Quantitative
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development - Yahoo Finance Singapore
Psyence Biomedical stock surges on Trump ibogaine announcement - Investing.com
Ibogaine could rise as potential psychedlic treatment with Trump announcement - Seeking Alpha
Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsLong Setup Ideas - vinanet.vn
Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd. Revenue Breakdown – NASDAQ:PBMWW - tradingview.com
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update - TipRanks
Psyence BioMed (Nasdaq: PBM) outlines psilocybin and ibogaine clinical plans - Stock Titan
Psyence Biomedical Warrant (PBMWW) Jumps 9.47% to $0.03 as Psychedelic Biotech Speculation IntensifiesBlock Trade Flow - vinanet.vn
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Enterprise value to EBITDA forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Psyence Biomedical (PBM) Falls 5.65% to $3.17 as Micro-Cap Biotech Faces Renewed Selling PressureSentiment Extreme - dars.gov.et
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Warrants (PBMWW) Surge 48%: A Closer Look at the Speculative MovePCR Spike - dars.gov.et
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PBM|Psyence Biomedical Ltd|Price:2.950|Chg%:+0.130 - TradingKey
Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBM|Psyence Biomedical Ltd|Price:3.580|Chg%:+0.230 - TradingKey
Psyence Biomedical Ltd (PBM) Cash Flow - TradingKey
Psyence Biomedical Ltd (PBM) Balance Sheet - TradingKey
Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PBM|Psyence Biomedical Ltd|Price:3.030|Chg%:+0.080 - TradingKey
Psyence Biomedical Ltd (PBM) Income Statement - TradingKey
Psyence Biomedical Company Profile & Introduction - Moomoo
Enterprise value to EBIT forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to earnings forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Psyence Biomedical (PBM) Slides 1.27% as Stock Tests Support Near $2.96Standard Deviation - dars.gov.et
Enterprise value to revenue forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Psyence Biomedical (PBM) Strengthens at Support – Biotech Stock Edges Higher Amid ConsolidationInsider Sentiment - vinanet.vn
Psyence Biomedical Warrant (PBMWW) Surges 22% – Can Low-Priced Momentum Continue?Block Trade Flow - vinanet.vn
Psyence Biomedical Ltd. (PBM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
PBMPsyence Biomedical Ltd Earnings - Finviz
Psyence Biomedical Ltd. (PBM) Retreats Amid Sector Caution: Support Levels Under ScrutinyIceberg Order - dars.gov.et
Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
$Psyence Biomedical (PBM.US)$ - Moomoo
Psyence Biomedical (PBM) Drops Over 6% as Shares Test Key Support LevelsSocial Sentiment - po-news-eg.net
Psyence Biomedical Ltd Azioni (PBM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):